|
Nenocorilant 200 mg Clinical Trials
1 actively recruiting trial across 1 location
Also known as: CORT125236
Pipeline
Phase 1/2: 1
Top Sponsors
- Corcept Therapeutics1
Indications
- Neoplasms1
- Cancer1
Los Angeles, California1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.